| Trading Companies & Distributors Industry | Industrials Sector | G. T. Cooper CEO | OTC PINK Exchange | - ISIN |
| GB Country | 7 Employees | - Last Dividend | 25 Jul 2025 Last Split | - IPO Date |
In Veritas Medical Diagnostics, Inc., represents a development stage company deeply entrenched in the advancement of medical technologies aimed at enhancing near-patient testing applications. Originating as In Vivo Medical Diagnostics, Inc., the company underwent a rebranding in 2005 to better reflect its broadened vision and mission in the medical diagnostics arena. Its foundation lies in the United Kingdom, specifically in Inverness, where it continues to push the boundaries of medical diagnostic capabilities with a focus on creating innovative solutions that cater to a wide range of patient needs and medical conditions.
The company's diverse pipeline of products under development demonstrates its commitment to leveraging cutting-edge technology to improve patient care and outcomes. Among its offerings, the following stand out: